mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

…, A Gallo, C Solaro, E Cocco, C Gasperini… - Journal of Neurology …, 2022 - jnnp.bmj.com
Multiple sclerosis (MS) is a chronic, immune-mediated disorder of the central nervous system.
A novel coronavirus, namely SARS-CoV-2, has been recently responsible for the highly …

Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis

…, A Ghezzi, M Rottoli, C Gasperini… - Functional …, 2009 - search.proquest.com
Swallowing problems can complicate the course of multiple sclerosis (MS). However, no
validated questionnaire for the assessment of dysphagia in MS is currently available. We …

Multiple Sclerosis Progression and Relapse Activity in Children

…, VB Morra, F Patti, M Zaffaroni, C Gasperini… - JAMA …, 2024 - jamanetwork.com
Importance Although up to 20% of patients with multiple sclerosis (MS) experience onset
before 18 years of age, it has been suggested that people with pediatric-onset MS (POMS) are …

Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis

…, C Scandellari, C Guaschino, C Gasperini… - Annals of …, 2021 - Wiley Online Library
Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people …

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

…, M Tintorè, JL Frederiksen, C Gasperini… - The Lancet …, 2016 - thelancet.com
In patients presenting with a clinically isolated syndrome, MRI can support and substitute
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination in …

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

…, M Filippi, J Frederiksen, C Gasperini… - The Lancet …, 2021 - thelancet.com
The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple
Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple …

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis

…, D Miller, CRG Guttmann, HL Weiner, C Gasperini… - The Lancet, 1999 - thelancet.com
Background Reliable prognostic factors are lacking for multiple sclerosis (MS). Gadolinium
enhancement in magnetic resonance imaging (MRI) of the brain detects with high sensitivity …

Deep gray matter volume loss drives disability worsening in multiple sclerosis

…, M Battaglini, S Ruggieri, C Gasperini… - Annals of …, 2018 - Wiley Online Library
Objective Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We
investigated whether there is a spatiotemporal pattern of GM atrophy that is associated with …

Progression of regional grey matter atrophy in multiple sclerosis

…, M Battaglini, S Ruggieri, C Gasperini… - Brain, 2018 - academic.oup.com
See Stankoff and Louapre (doi: 10.1093/brain/awy114 ) for a scientific commentary on this
article. Grey matter atrophy is present from the earliest stages of multiple sclerosis, but its …

Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies

C Tortorella, A Aiello, C Gasperini, C Agrati… - Neurology, 2022 - AAN Enterprises
Background and Objectives To evaluate the immune-specific response after full severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination of patients with multiple …